| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| icosapent | long-chain-fatty-acid--coa ligase 4 | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | inducer |
| icosapent | fatty acid-binding protein, brain | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | agonist |
| icosapent | fatty acid desaturase 1 | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | agonist |
| icosapent | free fatty acid receptor 1 | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | agonist |
| icosapent | peroxisome proliferator-activated receptor alpha | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | unknown |
| icosapent | peroxisome proliferator-activated receptor delta | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | agonist |
| icosapent | peroxisome proliferator-activated receptor gamma | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | agonist |
| icosapent | prostaglandin g/h synthase 1 | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | inhibitor |
| icosapent | prostaglandin g/h synthase 2 | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | inhibitor |
| icosapent | sodium/calcium exchanger 1 | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | inhibitor |
| icosapent | transient receptor potential cation channel subfamily v member 1 | small molecule | NA | drugbank | Hypertriglyceridemia[MeSHID:D015228] Disease[MeSHID:D004194] Diabetic Nephropathy[MeSHID:D003928] Cystic Fibrosis[MeSHID:D003550] Disease Progression[MeSHID:D018450] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malnutrition[MeSHID:D044342] |
NA | approved,nutraceutical | inducer |
| click here to return to the previous page | ||||||||